Korea-UK 2022

Invitation

Korea-UK Collaborative Seminar 2022
Cell therapy for cardiovascular disease - what’s next?
Friday 28th October 2022, 8:00-10:45am UK / 4:00-6:45pm Korea

Regenerative medicine remains an exciting and promising field of cardiology but still has many unanswered questions. In this year’s Korea-UK collaborative seminar, an international faculty of key opinion leaders will come together to discuss the current landscape, recent breakthroughs and the future directions of the field.

This conference forms part of the Korea-UK Collaborative, a unique faculty-led partnership between Chonnam National University Hospital, Queen Mary University of London and University College London for the purpose of facilitating academic exchange and joint research.

We hope that you will be able to join us for this important opportunity to reflect on what the field has accomplished so far and what’s next!

Korea-UK Collaborative Organising Committee

Programme

Korea-UK Collaborative Seminar 2022 (e-Conference)
Cell therapy for cardiovascular disease - what’s next?
Friday 28 October 2022, 8:00-10:35am UK / 4:00-6:35pm Korea
Time (UK)	Time (Korea)	Duration	Title	Speaker
8:00-8:05	4:00-4:05	5 min.	Introduction
8:00-8:05	4:00-4:05	5 min.	Opening Remarks Prof. Myung Ho Jeong (Chonnam National University Hospital, Korea)
			Welcoming address Prof. Youngkeun Ahn (President and CEO of Chonnam National University Hospital, Korea)
8:05-9:15	4:05-5:15	70 min.	Session 1. Methods of cell-based therapy
		Chairs:	Prof. Amrita Ahluwalia (Queen Mary University of London, UK) Prof. Myung Ho Jeong (Chonnam National University Hospital, Korea)
8:05-8:15	4:05-4:15	10 min.	Cell delivery methods: Life after NOGA Anthony Mathur (Queen Mary University of London, UK)
8:15-8:25	4:15-4:25	10 min.	Is there an ideal cell type? Philippe Menasché (Université Paris Cité, France)
8:25-8:35	4:25-4:35	10 min.	Bioengineering/scaffolds – the role of cells Doo Sun Sim (Chonnam National University Hospital, Korea)
8:35-8:45	4:35-4:45	10 min.	How close are we to a biological total artificial heart? Doris Taylor (CEO of Organamet Bio, Inc., USA)
8:45-8:55	4:45-4:55	10 min.	Are cells alone enough? Stefanie Dimmeler (Goethe University, Frankfurt Am Main, Germany)
8:55-9:05	4:55-5:05	10 min.	Cell transitions in cardiovascular disease Yong Sook Kim (Chonnam National University Hospital, Korea)
9:05-9:15	5:05-5:15	10 min.	Discussion Young Joon Hong (Chonnam National University Hospital, Korea) Dae Sung Park (Chonnam National University Hospital, Korea) Joon Ho Ahn (Chonnam National University Hospital, Korea) Daniel A. Jones (Queen Mary University of London, UK)
9:15-10:15	5:15-6:15	60 min.	Session 2: Disease targets for cell-based therapy
		Chairs:	Prof. Anthony Mathur (Queen Mary University of London, UK) Prof. Youngkeun Ahn (Chonnam National University Hospital, Korea)
9:15-9:25	5:15-5:25	10 min.	Cell therapy for acute myocardial infarction - the end of a chapter? Peter-Paul Zwetsloot (University of Utrecht, The Netherlands)
9:25-9:35	5:25-5:35	10 min.	Refractory angina Tim Henry (The Christ Hospital, USA)
9:35-9:45	5:35-5:45	10 min.	Ischaemic heart failure Emerson Perin (Texas Heart Institute, USA)
9:45-9:55	5:45-5:55	10 min.	Dilated cardiomyopathy Bojan Vrtovec (UMC Ljubljana, Slovenia)
9:55-10:05	5:55-6:05	10 min.	Precision cell therapy - what should we target? Mariann Gyöngyösi (Medical University of Vienna, Austria)
10:05-10:15	6:05-6:15	10 min.	Discussion Ju Han Kim (Chonnam National University Hospital, Korea) Kye Hun Kim (Chonnam National University Hospital, Korea) Jae Yeong Cho (Chonnam National University Hospital, Korea) John Martin (University College London, UK)
10:15-10:30	6:15-6:30	15 min.	Keynote lecture
10:15-10:30	6:15-6:30	15 min.	What’s next for the field? Giulio Pompilio (Centro Cardiologico Monzino, Italy)
10:30-10:35	6:30-6:35	5 min.	Close
10:30-10:35	6:30-6:35	5 min.	Closing remarks Anthony Mathur (Queen Mary University of London, UK)